Your prediction
Novozymes A/S B Stock
There is nearly no change for the Novozymes A/S B stock today. Compared to yesterday it only changed by €0.040.
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Novozymes A/S B | 0.080% | 1.121% | -4.699% | 10.450% | 5.081% | -12.274% | 26.806% |
Solvay S.A. A | 1.170% | -0.260% | 21.763% | -71.872% | 10.129% | -71.346% | -71.413% |
FMC Corp. | 2.560% | 0.663% | -7.920% | -51.280% | -5.238% | -44.443% | -23.194% |
Celanese Corp. A | 1.560% | -0.654% | -9.356% | 49.679% | 1.441% | 11.899% | 46.831% |